Anti-Obesity Drugs: A Review about Their Effects and Safety.

Diabetes & Metabolism Journal
Jun Goo Kang, Cheol-Young Park

Abstract

The current recommendations for the treatment of obese people include increased physical activity and reduced calories intake. When the behavioral approach is not sufficient, a pharmacologic treatment is recommended. In past years, numerous drugs have been approved for the treatment of obesity; however, most of them have been withdrawn from the market because of their adverse effects. In fact, amphetamine, rimonabant and sibutramine licenses have been withdrawn due to an increased risk of psychiatric disorders and non-fatal myocardial infarction or stroke. Even if orlistat is not as effective as other drugs in reducing body weight, orlistat is presently the only available choice for the treatment of obesity because of its safety for cardiovascular events and positive effects on diabetic control. Hopefully, more effective and better tolerated anti-obesity drugs will be developed through an improved understanding of the multiple mechanisms and complex physiological systems targeting appetite.

References

Aug 28, 1997·The New England Journal of Medicine·H M ConnollyH V Schaff
Jan 26, 1999·JAMA : the Journal of the American Medical Association·M H DavidsonS B Heymsfield
Apr 13, 2000·Archives of Internal Medicine·UNKNOWN National Task Force on the Prevention and Treatment of Obesity
Aug 30, 2001·Archives of Internal Medicine·G Glazer
Feb 19, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·C K HaddockM Ericsson
Jul 18, 2002·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·E Nisoli, M O Carruba
Nov 28, 2002·Eating and Weight Disorders : EWD·O BoselloC M Rotella
Aug 15, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·J KaukuaP Mustajoki
Sep 2, 2004·Nature Reviews. Drug Discovery·Vincenzo Di MarzoLuciano De Petrocellis
Dec 14, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ayca KayaCem Ekmekcioglu
Apr 6, 2005·Annals of Internal Medicine·Zhaoping LiSally C Morton
Nov 18, 2005·The New England Journal of Medicine·Jean-Pierre DesprésUNKNOWN Rimonabant in Obesity-Lipids Study Group
Feb 16, 2006·JAMA : the Journal of the American Medical Association·F Xavier Pi-SunyerUNKNOWN RIO-North America Study Group
Mar 30, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Lisa L Ioannides-DemosJohn J McNeil
Jun 28, 2007·European Heart Journal·Christian Torp-PedersenUNKNOWN SCOUT Investigators
Jul 12, 2007·JAMA : the Journal of the American Medical Association·Renee E AmoriAnastassios G Pittas
Oct 12, 2007·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Edoardo MannucciCarlo Maria Rotella
Nov 8, 2007·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·H S ParkH J Yoo
Nov 17, 2007·BMJ : British Medical Journal·Diana RuckerDavid C W Lau
Mar 4, 2008·Journal of Internal Medicine·W P T James
Nov 11, 2008·Recent Patents on Cardiovascular Drug Discovery·Ashish SamatG Neil Thomas
Jul 1, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·C CercatoA Halpern
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Amel SaadiRebecca C Fitzgerald
Feb 17, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·L J AronneJ M Amatruda
Mar 10, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J ProiettoJ M Amatruda
Mar 30, 2010·Journal of Pain & Palliative Care Pharmacotherapy· U S Food And Drug Administration
Jun 18, 2010·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Mira Harrison-WoolrychPeter Herbison
Jul 22, 2010·The New England Journal of Medicine·Steven R SmithUNKNOWN Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group
Jul 22, 2010·The New England Journal of Medicine·Arne Astrup
Aug 4, 2010·Nature Reviews. Endocrinology·Marion L VetterThomas A Wadden
Sep 8, 2010·The New England Journal of Medicine·W Philip T JamesUNKNOWN SCOUT Investigators
Feb 19, 2011·Journal of Obesity·Mariela Glandt, Itamar Raz
Jun 10, 2011·Clinical Pharmacology and Therapeutics·A G PowellL J Aronne
Jul 29, 2011·The Journal of Clinical Endocrinology and Metabolism·Meredith C FidlerUNKNOWN BLOSSOM Clinical Trial Group

❮ Previous
Next ❯

Citations

Oct 26, 2013·Journal of Pharmacokinetics and Pharmacodynamics·Peter GennemarkJohan Gabrielsson
May 17, 2013·Endocrine·Guido Di DalmaziUberto Pagotto
Apr 16, 2013·Archives of Pharmacal Research·Kung-Woo NamMan-Deuk Han
Jun 19, 2013·Journal of Medicinal Food·Judith S SternPoorna Rajeswari Konda
Apr 11, 2014·International Journal of Endocrinology and Metabolism·David Palacios-MartinezRaquel Asuncion Diaz-Alonso
Sep 19, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jose Angelo A De Dios, Steven D Brass
Nov 13, 2014·Journal of Pharmacokinetics and Pharmacodynamics·Peter GennemarkJohan Gabrielsson
Jan 17, 2016·Analytical Biochemistry·Chaela S PresleyBob M Moore
Nov 26, 2014·International Journal of Molecular Sciences·Hee Soong JungEun-Kyoung Kim
Nov 30, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Muhammad Abubakar AdoHasanah M Ghazali
Mar 12, 2013·Expert Review of Clinical Pharmacology·Julia KenkreStephen Bloom
Feb 24, 2016·International Journal of Food Sciences and Nutrition·Tao WuXiaodong Zheng
Jul 30, 2015·Phytochemical Analysis : PCA·Jihe TangZhihong Cheng
Jan 8, 2016·Obesity Research & Clinical Practice·Meriga BalajiSreenivasulu Dasari
Sep 26, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Sunju ParkSeong-Gyu Ko
Sep 8, 2015·Metabolism: Clinical and Experimental·Dhiren Patel
Jan 22, 2013·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·E W ChanI C K Wong
Mar 21, 2013·Obesity·Bryan A LiangLinda M Shinn
Mar 13, 2014·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A ChatzigeorgiouM Koutsilieris
Jun 14, 2014·Journal of Clinical Pharmacy and Therapeutics·C P WalterM P Dorsch
Jan 25, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Thierry HanhPatrick Blin
Mar 14, 2014·Nutritional Neuroscience·Cristina Torres-FuentesJohn F Cryan
Nov 26, 2015·Ancient Science of Life·Parveen Kumar, Uma Bhandari
Apr 1, 2015·Clinical Obesity·D SallD Schauer
Nov 2, 2013·Toxicology Mechanisms and Methods·Mohammad Rafiul HaqueMohammed Afroz Ahmad
Jan 25, 2013·The Korean Journal of Internal Medicine·Jun Goo Kang, Cheol-Young Park
May 29, 2014·BioMed Research International·Parveen KumarShrirang Jamadagni
Feb 26, 2013·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Kaisa M LinderborgAndrew J Sinclair
Jul 23, 2014·Economics and Human Biology·Jonas Minet Kinge, Stephen Morris
Apr 1, 2015·Future Medicinal Chemistry·Luca Costantino, Daniela Barlocco
Dec 30, 2014·Drug Discovery Today·Luis F Alguacil, Carmen González-Martín
Oct 31, 2014·Behavioural Pharmacology·Anushka V GoonawardenaGernot Riedel

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Software Mentioned

EQUIP
Contrave
NeuroSearch
COR
BMOD
CONQUER
BLOSSOM
EQUATE
Diabetes

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.